Skip to main content
All lobbying filings

Drug Policy Alliance

Drug Policy Alliance filed a Q1 report for Drug Policy Alliance on April 20, 2025.

Lobbying for Drug Policy Alliance

As filed: DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE.

All filings by Drug Policy Alliance · Everything Drug Policy Alliance has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 20, 2025
Expenses
$10,353
What this organization spent lobbying with its own staff. Reported using IRS section 6033(b)(8) definitions (method B): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Lobbyists on this filing 1
  • HANNA SHARIF-KAZEMI
    Previously held: Policy Manager

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 3
Law Enforcement/Crime/Criminal Justice

We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).

Civil Rights/Civil Liberties

We led coalitions in support of the RESTORE Act (118th Congress - S. 1753/H.R. 3479), a bill that would get rid of the SNAP drug felony ban, and the Thurmond Amendment via a bill called the Fair Future Act (118th Congress - H.R. 9694/S. 5111).

Health Issues

We urged Congress to fully fund health programs that support people struggling with addiction in Congressional spending bills.

 Bills named in this filing 7

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem